Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors

Pain

Volumn 96, Issue 3, 2002, Pages 353-363

  Taiwo, Oludare B ^a   Taylor, Bradley K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Carrageenan; Complete Freund's adjuvant; Inflammation; Neuropeptide tyrosine; Pain; Rat; Spinal cord; Y1 receptor

Indexed keywords

CARRAGEENAN; FREUND ADJUVANT; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; HOT PLATE TEST; HYPERALGESIA; INFLAMMATION; LATENT PERIOD; MALE; MOTOR COORDINATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SKIN TEMPERATURE; STIMULUS RESPONSE; TASK PERFORMANCE; THERMAL STIMULATION; WITHDRAWAL REFLEX;

ACUTE DISEASE; ANIMALS; ARGININE; BODY TEMPERATURE; CARRAGEENAN; DISEASE MODELS, ANIMAL; FREUND'S ADJUVANT; HEAT; HYPERALGESIA; INJECTIONS, SPINAL; MALE; MOTOR ACTIVITY; NEUROGENIC INFLAMMATION; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; SPINAL CORD;

EID: 0036220189     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00481-X     Document Type: Article

References (49)

1. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226
2. Neuropeptide Y distribution in human brain
3. Neuropeptide Y in the trigeminal ganglion following chronic constriction injury of the rat infraorbital nerve: Is there correlation to somatosensory parameters?
4. 2+ influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor
5. Carrageenan-induced inflammation of the hind foot provokes a rise of GABA-immunoreactive cells in the rat spinal cord that is prevented by peripheral neurectomy or neonatal capsaicin treatment
6. Hemodynamic and sympathetic effects of spinal administration of neuropeptide Y in rats
7. Balances between excitatory and inhibitory events in the spinal cord and chronic pain
8. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli
9. Microinjection of neuropeptide Y into the superficial dorsal horn reduces stimulus-evoked release of immunoreactive substance P in the anaesthetized cat
10. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist
11. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries
12. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers
13. Evaluation of NPY Y1 agonist effects on exocytotic activity from central and peripheral terminals of capsaicin-sensitive nociceptors
14. The distribution and origin of a novel brain peptide, neuropeptide Y, in the spinal cord of several mammals
15. Neuropeptide Y: Coexistence with noradrenaline. Functional implications
16. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
17. Messenger plasticity in primary sensory neurons following axotomy and its functional implications
18. Neuropeptide Y: Some viewpoints on a multifaceted peptide in the normal and diseased nervous system
19. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus
20. The antinociceptive effects of spinally administered neuropeptide Y in the rat: Systematic studies on structure-activity relationship
21. Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation
22. Quantitative autoradiographic localization of [125I]neuropeptide Y receptor binding sites in rat spinal cord and the effects of neonatal capsaicin, dorsal rhizotomy and peripheral axotomy
23. Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release
24. Some sensory neurons express neuropeptide Y receptors: Potential paracrine inhibition of primary afferent nociceptors following peripheral nerve injury
25. The release of immunoreactive neuropeptide Y in the spinal cord of the anaesthetized rat and cat
26. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
27. Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor
28. Quantification of axotomy-induced alteration of neuropeptide mRNAs in dorsal root ganglion neurons with special reference to neuropeptide Y mRNA and the effects of neonatal capsaicin treatment
29. Lumbar catheterization of the subarachnoid space with a 32-gauge polyurethane catheter in the rat
30. The types of neuron which contain protein kinase C gamma in rat spinal cord
31. Evidence that neuropeptide Y is present in GABAergic neurons in the superficial dorsal horn of the rat spinal cord
32. Intrathecal catheterization in the rat. Improved technique for morphologic analysis of drug-induced injury
33. Distribution of neuropeptide Y-like immunoreactivity and its relationship to FMRF-amide-like immunoreactivity in the sixth lumbar and first sacral spinal cord segments of the rat
34. Regulation of galanin and neuropeptide Y in dorsal root ganglia and dorsal horn in rat mononeuropathic models: Possible relation to tactile hypersensitivity
35. Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord
36. Lumbar catheterization of the spinal subarachnoid space in the rat
37. Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide
38. Pathophysiologic mechanisms of neuropathic pain
39. Effects of peripheral nerve injuries and tissue inflammation on the levels of neuropeptide Y-like immunoreactivity in rat primary afferent neurons
40. 2+ currents in rat sensory neurons
41. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents
42. Neuronal plasticity: Increasing the gain in pain
43. The effects of intrathecal neuropeptide Y on the spinal nociceptive flexor reflex in rats with intact sciatic nerves and after peripheral axotomy
44. The effect of intrathecal neuropeptide Y on the flexor reflex in rats after carrageenan-induced inflammation
45. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries
46. Topical capsaicin treatment suppresses formalin-evoked fos expression in rat spinal cord
47. Localization of neuropeptide Y Y1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons
48. Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia
49. The neuropeptide Y Y1 receptor is a somatic receptor on dorsal root ganglion neurons and a postsynaptic receptor on somatostatin dorsal horn neurons